These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1381245)

  • 1. FK 506: a new immunosuppressive agent for organ transplantation. Pharmacology, mechanism of action and clinical applications.
    Fagiuoli S; Gasbarrini A; Azzarone A; Francavilla A; Van Thiel DH
    Ital J Gastroenterol; 1992; 24(6):355-60. PubMed ID: 1381245
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)].
    Díaz M; Azanza JR; Sádaba B; López de Ocáriz A
    Rev Med Univ Navarra; 1995; 39(1):28-40. PubMed ID: 14735715
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus (FK506) for organ transplants.
    Med Lett Drugs Ther; 1994 Sep; 36(931):82-3. PubMed ID: 7520968
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical pharmacokinetics and therapeutic monitoring of tacrolimus].
    Garraffo R
    Therapie; 1997; 52(4):345-52. PubMed ID: 9437890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of calcineurin antagonists.
    Kapturczak MH; Meier-Kriesche HU; Kaplan B
    Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation.
    Jacobson P; Uberti J; Davis W; Ratanatharathorn V
    Bone Marrow Transplant; 1998 Aug; 22(3):217-25. PubMed ID: 9720734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tacrolimus (FK 506): an immunosuppression alternative in solid organ transplantation. (Part 2)].
    Díaz M; Azanza JR; Sádaba B; López de Ocáriz A
    Rev Med Univ Navarra; 1995; 40(2):93-108. PubMed ID: 7569553
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving tolerability of immunosuppressive regimens.
    MacDonald A
    Transplantation; 2001 Dec; 72(12 Suppl):S105-12. PubMed ID: 11833142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents--comparison with cyclosporin A].
    Sakai K; Date I; Yoshimoto Y; Arisawa T; Nakashima H; Furuta T; Asari S; Nishimoto A
    No To Shinkei; 1991 May; 43(5):461-6. PubMed ID: 1716937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of tacrolimus in pancreas transplantation.
    Wijnen RM; Ericzon BG
    Diabet Med; 1997 Nov; 14(11):911-8. PubMed ID: 9400914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of calcium-channel antagonists in solid organ transplantation.
    Huntress JD; Papadakos PJ
    New Horiz; 1996 Feb; 4(1):129-33. PubMed ID: 8689268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FK-506. A new immunosuppressive drug].
    MacLeod AM; Thomson AW
    Medicina (Firenze); 1990; 10(3):329-32. PubMed ID: 1706817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder transplantation in rats using FK-506.
    Yamataka A; Wang K; Kobayashi H; Lane G; Miyahara K; Sueyoshi N; Miyano T
    J Urol; 2001 Jul; 166(1):259-62. PubMed ID: 11435882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis.
    Miyata S; Ohkubo Y; Mutoh S
    Inflamm Res; 2005 Jan; 54(1):1-9. PubMed ID: 15723198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients.
    Karasu Z; Gurakar A; Carlson J; Pennington S; Kerwin B; Wright H; Nour B; Sebastian A
    J Okla State Med Assoc; 2001 Apr; 94(4):121-3. PubMed ID: 11392178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group.
    Transpl Int; 1994; 7 Suppl 1():S247-51. PubMed ID: 11271216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.